BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2021
View Archived Issues
Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo
Read More
Merck & Co.'s [11C]L-235 can be used to assess target engagement of cathepsin K inhibitors
Read More
AbbVie initiates first-in-human study of ABBV-623 and ABBV-992
Read More
Nanjing Ruijie Pharma divulges ACC inhibitors
Read More
Nerviano Medical Sciences patents IDH inhibitors
Read More
Bayer presents new alpha2C-adrenoceptor antagonists
Read More
Jiangsu Simcere Pharmaceutical identifies new PRMT5 inhibitors
Read More
Shanghai SIMR Biotech synthesizes new PLA2G7 inhibitors
Read More
Phase I data for anti-PCSK9 peptide vaccine candidates AT-04A and AT-06A
Read More
Second cohort data from phase I/II study of NOX-A12 in glioblastoma multiforme
Read More
GPR55 promotes NASH development through ACC activation
Read More
EC-11770 shows broad-spectrum activity in nontuberculous mycobacterial infection models
Read More
Inflammation, depression share "core biological process"
Read More
SPK-10000, a liver-targeted gene therapy for the treatment of hereditary angioedema
Read More
Preclinical data show antiviral and anti-inflammatory activity of balixafortide in COVID-19
Read More
AB Science suspends inclusion in masitinib trials
Read More
Phase IIb study of vamorolone in Duchenne muscular dystrophy meets primary endpoint
Read More
FDA clears IND for anti-CD73 antibody HLX-23 for advanced solid tumors
Read More
Pivotal study of venglustat in ADPKD stopped for futility
Read More
CARB-X supports BioVersys' development of pyrrolocytosines targeting antibiotic-resistant bacteria
Read More
Neuren holds pre-IND meetings for phase II trials of NNZ-2591 for neurological disorders
Read More
